New oral weight loss pill shows promise as cheaper alternative to injections

A new once-a-day pill, orforglipron, shows promise for weight loss, potentially offering a cheaper alternative to current injectable GLP-1 drugs. The pill, a GLP-1 agonist, helped participants lose up to 9.6% of their body weight in a study, and also improved blood sugar levels. Orforglipron is expected to be more accessible due to its oral form, lower manufacturing costs, and lack of special storage or fasting requirements.